Table 1.
Available Route of Dose |
Relative Equivalent Potency | Onset of Action (After Oral Administration) | Peak Blood Levels (Hours) |
Half-Life (Hours) |
Duration of Action | Metabolism | |
---|---|---|---|---|---|---|---|
Chlordiazepoxide | PO | 10 | Intermediate | 0.5–2 | 24–48 | Long | Hepatic |
Clorazepate | PO, IM | 7.5 | Rapid | 0.5–2 | 48 (active metabolite) | Short | Hepatic |
Diazepam | PO, IM, IV, PR | 5 | Rapid | Oral: 0.25–2.5 IM: 1 IV: 0.01 |
30–60 | Long | Hepatic |
Lorazepam | PO, IM, IV | 1 | Intermediate | Oral: 2 IM: ≤3 |
12–18 | Short to medium | Hepatic |
Midazolam | PO, IM, IV | 2 | Rapid | Oral: 0.2–2.5 IM: 0.5–1 |
2–7 | Short | Hepatic, gut |
Notes: Data from Botswick J.87
Abbreviations: AWS, alcohol withdrawal syndrome; PO, per os; IM, intramuscularly; IV, intravenously; PR, per rectum.